An important aspect of vascular biology is the identification of regulators of stress-sensitive genes that play critical roles in mediating inflammatory response. Here, we show that expression of HuR in human umbilical vein endothelial cells is regulated by shear stress and statin treatment; HuR, in turn, regulates other stress-sensitive genes such as Kruppel-like factor 2 (Klf2), endothelial nitric oxide synthase (eNOS), and bone morphogenic protein 4 (BMP-4). We found that siRNA knockdown of HuR-inhibited inflammatory responses in endothelial cells, including ICAM-1 and VCAM-1 up-regulation, NFκB phosphorylation, and adhesion of monocytes. Tissue staining of the mouse aorta revealed increased HuR expression in the lesser curvature region of the arch that is exposed to disturbed flow, consistent with our in vitro data. Taken together, these results suggest that HuR plays a critical role in inducing inflammatory response of endothelial cells under mechanical and biochemical stresses.
HuR | mechanosensitivity | shear stress | NFκB A therosclerosis is known as an inflammatory disease that occurs preferentially in branched or curved arterial regions where endothelial cells are exposed to disturbed shear flow (1-4). Blood flow-induced shear stress can alter the expression of "stresssensitive" genes in endothelial cells, including Kruppel-like factor 2 (Klf2) that has antiatherosclerotic functions (herein referred to as an "antiatherosclerotic gene") and bone morphogenic protein 4 (BMP-4) that has proatherosclerotic functions (herein referred to as a "proatherosclerotic gene") (5) . Klf2 is an endothelial transcription factor that suppresses the proatherosclerotic signaling pathway (6, 7) . It has been reported that Klf2 regulates proinflammatory activation in endothelial cells, and a high level of Klf2 inhibits vascular cell adhesion molecule 1 (VCAM-1) expression (7) . In contrast, BMP-4 promotes the activation of atherosclerotic signaling pathway and stimulates the production of adhesion molecules in endothelial cells (8) (9) (10) . The expression of adhesion molecules in endothelial cells, such as ICAM-1 (intercellular adhesion molecule 1) and VCAM-1 is regulated by activated nuclear factor kappa B (NFκB, a major transcriptional factor), which can be found in atherosclerotic lesions. NFκB also exists in an inactive form by binding to the inhibitor of nuclear factor kappa B (IκB) in the cytosol. Various stimuli including bacterial lipopolysaccharide (LPS) can induce phosphorylation and degradation of IκB, allowing the activation of NFκB. An increased level of adhesion molecules in endothelial cells recruits monocyte binding to cell surface, which is an important indicator of inflammatory response.
To understand inflammation in cardiovascular disease and other human diseases, it is essential to identify and characterize stresssensitive genes and their regulators in endothelial cells that play important roles in mechanosensing and signal transduction (11) (12) (13) (14) (15) (16) . One candidate of stress-sensitivity regulator gene is HuR, which belongs to the embryonic lethal abnormal visual family of RNA binding protein and is ubiquitously expressed (17, 18) . It is known that HuR protein binds to the AU-rich elements (AREs) of the 3′ untranslated region (3′ UTR) of certain mRNAs with high affinity, resulting in an increased stability and translation of these mRNAs (19) (20) (21) . Recently, it has been found that HuR increases the stability of toll-like receptor 4 (TLR4) mRNA in vascular smooth muscle cells (VSMCs) (22) . It also contributes to the proliferation of VSMCs, as revealed by platelet-derived growth factor (PDGF) treatment and HuR knockdown experiments (23) . It has been reported that HuR regulates the stability of c-fos, vascular endothelial growth factor and TLR4 mRNAs (19, 22, (24) (25) (26) . However, HuR has not been identified as a regulator for stress-sensitive genes, and its role in atherosclerosis has not been well characterized.
Although the role of HuR in mechanotransduction and atherosclerosis has not been well studied, we noted that its known functions in the stabilization of the mRNAs of genes implicated in the regulation of cellular growth, angiogenesis, and rapid inflammatory response made it an ideal candidate for an effector that allows mechanical and biochemical stresses to modify inflammatory responses. In this work, we demonstrate that HuR is a regulator of stress-sensitive genes involved in both pro-and antiatherosclerotic responses in endothelial cells. Further, siRNA knockdown of HuR can significantly inhibit the inflammatory responses of endothelial cells. These findings can help understand mechanotransduction in endothelial cells and develop better treatment strategies of atherosclerosis.
Results
HuR Changes Its Expression in Response to in Vitro Shear Flow.
Inflammatory disease is preferentially generated in the arterial regions where endothelial cells are exposed to disturbed shear flows. In contrast, endothelial cells under laminar shear flow (LS) show antiinflammatory responses and are relatively free of atherosclerotic lesions. In this study, oscillatory shear flow (OS) with low amplitude was used to mimic disturbed flow in vivo. To determine whether HuR is a shear stress-sensitive gene, i.e., whether HuR expression is differentially regulated by different types of shear flow, we applied, respectively, LS and OS to human umbilical vein endothelial cells (HUVECs) for 24 h and analyzed the mRNA levels of HuR. We found that HuR mRNA level increased by ≈1.7-fold under the OS condition and ≈1.3-fold under the LS condition compared with that under the static condition (Fig. 1A) . For comparison, we also quantified the changes in mRNA level of Klf2, eNOS, and BMP-4 under OS and LS conditions, as shown in Fig. 1 B-D , respectively. Specifically, under the OS condition, the antiatherosclerotic genes, Klf2 and eNOS, had almost no change in their mRNA levels, but the proatherosclerotic gene BMP-4 increased its mRNA level by ≈1.5-fold compared with the static condition. On the other hand, under the LS condition, the mRNA levels of Klf2 and eNOS had To whom correspondence may be addressed. E-mail: gang.bao@bme.gatech.edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/ 1000444107/DCSupplemental. large increases (20-and 4.5-fold increase, respectively), but BMP-4 had an ≈2-fold decrease in its mRNA level compared with the static condition. Because BMP-4 is a proatherosclerotic gene, and disturbed shear flow is known to induce inflammatory response of blood vessels, the similarity of HuR and BMP-4 expression under the OS condition suggests that HuR is a proatherosclerotic gene. Further, it is reasonable to assume that HuR is involved in a signaling pathway different from that of BMP-4 due to the different behavior of HuR and BMP-4 under the LS conditions.
To determine whether HuR expression changes in vivo in response to shear stress, we carried out en face staining for endothelial HuR protein in three different locations of mouse aorta. The thoracic aorta (TA) and the greater curvature (GC) regions of the arch are mostly exposed to the undisturbed flow with predominantly unidirectional shear stress, which corresponds to the atheroresistant region (27, 28) . In contrast, the lesser curvature (LC) region of the arch corresponds to the atheroprone region, where the endothelial cells are exposed to the disturbed flow. As clearly shown in Fig. 1E , there was an increased amount of cytosolic HuR in endothelial cells in the LC region compared with that in the TA and GC regions. To confirm the specificity of the HuR antibody used, we injected 20 μg/mL actinomycin D (ActD) to mouse, because ActD is known to induce the release of HuR protein from the cell nucleus to cytosol. En face staining of the TA regions from control (EtOH) and ActD-treated mice indicated that the antibody could clearly show the cytosolic release of HuR protein (SI Text and Fig. S1 ). Therefore, our results suggest that HuR is a stresssensitive gene that can be up-regulated by the disturbed flow.
HuR Expression Is Regulated by Statin Treatment. We further quantified the expression of HuR, Klf2, eNOS, and BMP-4 in HUVECs after statin treatment by using RT-PCR. Statins are known as an inhibitor of 3-hydroxy-3-methylglutaryl CoA (HMGCoA reductase) and can reduce LDL levels, thus inhibits inflammation; they have been used as a drug for treating cardiovascular disease. In addition to lipid lowering, it regulates the expression of stress-sensitive genes such as Klf2 and eNOS in endothelial cells (29) (30) (31) (32) . Therefore, we treated endothelial cells with statin to determine if the expression of HuR is regulated by statin treatment, thus revealing the role HuR plays in inflammatory response. Cells were treated with either 10 μM mevastatin or DMSO (as control) for 24 h. As shown in Fig. 1F , with statin treatment, the Klf2 mRNA level increased by almost 10-fold while the mRNA level of eNOS increased by ≈1.5-fold compared with control cells. In contrast, both BMP-4 and HuR mRNA levels decreased by ≈2-fold after statin treatment (Fig. 1F ). BMP-4 is a proatherosclerotic gene (8, 9) , and the infusion of BMP-4 in mice induced hypertension and endothelial dysfunction in a vascular NADPH oxidase-dependent manner (10) . The similarity of HuR and BMP-4 in their responses to the OS condition and statin treatment provides further evidence that HuR is a proatherosclerotic gene.
HuR Expression Is Regulated by Shear Stress in Vivo. To determine whether HuR expression is regulated in vivo due to an inflammatory response, we analyzed HuR mRNA level in a partial ligation model of mouse carotid in which the left carotid artery (LCA) was partially ligated to create disturbed flow, while the right carotid artery (RCA) served as an internal control (under laminar flow). Endothelial RNA from sham (control) and partially ligated C57BL/6 mice were collected 2 days after surgery and analyzed by real-time PCR. Our RT-PCR analysis indicated that in the sham operation (control) group, the difference in HuR mRNA level between LCA and RCA was small (≈10%); however, there was a 1.9-fold increase of HuR mRNA level in ligated LCA compared with nonligated RCA (Fig.  1G ), indicating that HuR expression level is up-regulated in endothelial cells exposed to disturbed flow conditions. This result is consistent with the previous results that Klf-2 and eNOS mRNA levels were significantly down-regulated in LCA, whereas BMP-4 mRNA level was up-regulated in LCA compared with RCA (33) . Together with the en face staining results shown in Fig. 1E , this in vivo experiment provides further evidence that HuR is differentially regulated by blood flow shear stress.
HuR Regulates Other Stress-Sensitive Genes in HUVECs. To determine whether HuR regulates the expression of other genes that have pro-or antiatherosclerotic functions, we used HuR siRNA to knock down the level of HuR in HUVECs and quantified the changes in the expression level of Klf2, eNOS, and BMP-4 mRNAs. Cells were transfected with either HuR siRNA or nonsilencing (NS) siRNA as control and incubated for 2 days before RNA isolation. As shown in Fig. 2 , siRNA knockdown of HuR decreased HuR mRNA level by 90% in HUVECs compared with that of control cells ( Fig. 2A) , at the same time, Klf2 and eNOS mRNA levels increased by 2.6-and 1.8-fold, respectively (Figs. 2 B and C), and BMP-4 mRNA level decreased by 60% (Fig. 2D) . Evidently, the reduction of HuR expression level induced an increase in the expression of known antiatherosclerotic genes (KLF2 and eNOS) and a decrease in the expression of known proatherosclerotic gene (BMP-4). This result further supports the conclusion that HuR is a proatherosclerotic gene.
How does HuR affect the expression of Klf2, eNOS, and BMP-4, and vice versa? It is unlikely that HuR protein binds directly to Klf2 or eNOS, because HuR typically increases the stability of specific mRNAs it binds to; therefore, knockdown of HuR would reduce the stability (and thus the amount) of these mRNAs. However, it is possible that HuR directly interacts with BMP-4 mRNA, because 90% knockdown of HuR mRNA reduced the expression level of BMP-4 by 60%. To investigate this possibility, HUVECs transfected with HuR siRNA were further treated with statin or recombinant BMP-4. Specifically, HUVECs were transfected with HuR siRNA for 2 days followed by incubation with 10 μM statin or 100 ng/mL BMP-4 protein for 24 h. As a control, cells were transfected with NS siRNA and treated with statin or BMP-4. As shown in Fig. 3A , compared with cells transfected with NS siRNA only, further BMP-4 treatment had no effect on HuR expression level, whereas statin treatment decreased HuR level, consistent with the result shown in Fig. 1F . Relative to NS siRNAtreated cells, HuR siRNA knockdown reduced HuR mRNA levels by 70% 3 days after transfection. Additional statin treatment further decreased the HuR mRNA level, but additional BMP-4 protein treatment had essentially no effect on HuR level (Fig. 3A) .
We also analyzed the Klf2 and BMP-4 mRNA levels under the same experimental conditions as described above. As shown in Fig.  3B , relative to HUVECs with NS siRNA transfection only, additional statin treatment increased Klf2 mRNA level by ≈6-fold, but BMP-4 protein treatment had no effect on Klf2 expression level (Fig. 3B) . Specific HuR knockdown with siRNA increased the Klf2 mRNA level by 2.5-fold, and additional statin treatment resulted in an increase of Klf2 mRNA level by 9-fold, much higher than that in statin-treated, NS siRNA-transfected cells. This result suggests a synergic (additive) effect of HuR knockdown and statin treatment on the up-regulation of Klf2 mRNA in HUVECs. Additional BMP-4 protein treatment, however, only induced a very small increase in Klf2 mRNA level (Fig. 3B) . With NS siRNA transfection, the BMP-4 mRNA level in HUVECs decreased by 35% upon statin treatment and increased by 10% after BMP-4 protein treatment, as shown in Fig. 3C . With HuR siRNA knockdown, the BMP-4 mRNA level in HUVECs decreased by ≈40% with and without statin treatment, but the decrease was only ≈20% when BMP-4 protein treatment was carried out in addition to HuR knockdown (Fig. 3C) . Taken We performed additional experiments to combine HuR knockdown and the application of shear stress. The oscillatory shear stress was used as the stimulus for proatherosclerotic signal and laminar shear stress as control. As shown in Fig. S2A , there was an increase in HuR mRNA level under the OS flow compared with that under LS flow, with and without HuR knockdown (Fig. S2A) . Further, the Klf2 mRNA level was reduced significantly by OS in cells with and without HuR knockdown, compared with that under LS flow (Fig. S2B) . With NS siRNA-transfected cells, BMP-4 expression level increased by 2.5-fold under OS flow as compared with that with LS flow (as control); however, the exposure of cells with HuR knockdown to LS flow did not further decrease the level of BMP-4 mRNA (Fig. S2C) , whereas under OS flow, HuR knockdown reduced BMP-4 mRNA level. Therefore, our data suggest that the effects of shear stress and HuR knockdown on the expression of stress-sensitive genes are coupled. (Fig. S3B) . However, it is unclear if the increased Klf2 expression level after HuR knockdown (Fig. 2B) is due to the increased stability of Klf2 mRNA. Note that in Fig. S3 A and B, the mRNA levels at different time points were normalized respectively by that at t = 0, which are the Klf2 mRNA levels shown in Fig. S3C at the onset of ActD treatment, with and without HuR knockdown or LPS treatment. Interestingly, LPS treatment reduced the Klf2 level by >2-fold in control cells (with NS siRNA transfection), but only reduced the Klf2 level slightly in cells with HuR knockdown (Fig. S3C) .
Similarly, without LPS treatment, the half-life of BMP-4 increased from 1.84 h to 3.0 h because of HuR knockdown (Fig.  S3D ). This result clearly suggests that HuR protein does not bind to BMP-4 mRNA to increase its stability (and thus the level), because BMP-4 level decreased by 2.5-fold after HuR knockdown. With LPS treatment, the half-life of BMP-4 increased from 2.48 h in control cells to 3.18 h in cells with HuR knockdown (Fig. S3D) . The mRNA levels at the onset of ActD treatment, with and without HuR knockdown and LPS treatment, are shown in Fig. 4F . We found that LPS treatment did not alter the BMP-4 mRNA level in HUVECs with and without HuR knockdown (Fig. S3F) .
Pull-down of HuR protein-mRNA complexes followed by real-time PCR revealed that none of the mRNAs of interest (Klf2, eNOS, BMP-4) were detected, indicating that HuR protein did not bind to those mRNAs (SI Text and Fig. S4 ). Therefore, we conclude that the regulation of Klf2 and BMP-4 levels by HuR was not due to changes of mRNA stability by direct HuR protein binding. Further studies such as microarray analysis using cDNAs from RNA-HuR protein immunoprecipitation samples are needed to reveal what RNAs bind to HuR. HuR Knockdown Inhibits Inflammatory Response. The results shown in Figs. 1 and 2 suggest that HuR is a stress-sensitive gene that promotes the inflammatory response in endothelial cells. To determine whether HuR knockdown induced molecular-level changes in inflammatory responses give rise to physiological consequences, we quantified changes in monocyte binding to endothelial cells. Cells were transfected with NS siRNA and HuR siRNA, respectively, for 3 days, followed by LPS treatment for 4 h before they were incubated with monocytes for quantifying the degree of binding. We found that, compared with control cells (NS siRNAtransfected cells without LPS treatment), LPS treatment increased monocyte binding by almost 12-fold (Fig. 4A) . However, HuR knockdown greatly reduced monocyte binding upon LPS treatment (only 1.8-fold increase compared with cells without LPS treatment).
To understand the molecular mechanism(s) of HuR in affecting inflammation, we examined the effect of HuR knockdown on the expression of adhesion molecules ICAM-1 and VCAM-1. We transfected HUVECs with NS siRNA and HuR siRNA, respectively, for 3 days, followed by LPS treatment for 4 h. As shown in Fig.  4B , LPS treatment induced a 60-fold increase in ICAM-1 mRNA level in cells with NS siRNA transfection; the increase was significantly reduced (only ≈20-fold) in cells with HuR siRNA knockdown. Similarly, LPS treatment induced a dramatic (≈500-fold) increase in VCAM-1 expression level in cells with NS siRNA transfection. However, HuR knockdown significantly reduced the effect of LPS treatment on VCAM-1 expression (Fig. 4C) . The same trend was true for ICAM-1 and VCAM-1 protein levels, as shown in Fig. 4D . Further, we found that HuR knockdown almost completely blocked the PMA-induced up-regulation of VCAM-1 protein; it also reduced the PMA up-regulation of ICAM-1 protein level (Fig. 4D) . Our results suggest that HuR mediates the inflammatory response, as demonstrated by the effect of HuR knockdown on the expression of ICAM-1 and VCAM-1 in LPS-treated endothelial cells.
Effect of HuR on VCAM-1 Expression Was Mediated by NFκB. To investigate whether the effect of HuR knockdown on the expression of adhesion molecules, especially VCAM-1, was mediated by the transcription factor NFκB, cellular fractionation followed by Western blotting (Fig. 4E ) and chromatin immunoprecipitation (ChIP) analysis by using NFκB p65 antibody (Fig. 4F) were performed. We first examined the subcellular localization of NFκB p65 before and after LPS treatment in NS siRNA or HuR siRNA-transfected cells. Specifically, 3 days after transfection of NS or HuR siRNA, cells were treated with LPS for 1 h and then fractionated into nuclear and cytosolic fractions. The result of Western blotting shown in Fig. 4E indicates that in both nuclear and cytosolic fractions of LPS-treated cells, HuR knockdown reduced the amount of phosphorylated NFκB compared with control (NS siRNA-transfected) cells. Further, compared with control cells, HuR knockdown significantly reduced the amount of NFκB translocated into nucleus and slightly increased the amount of cytosolic NFκB. This suggests that HuR facilitates the phosphorylation of NFκB in LPS-treated cells and the nuclear translocation of NFκB. We then performed ChIP analysis in which immunoprecipitated samples by NFκB antibody were subjected to PCR amplification by using primers for the human VCAM-1 promoter region that NFκB binds (34) . As shown in Fig. 4F , with HuR knockdown, no VCAM-1 can be detected in the ChIP assay in LPStreated cells, in shape contrast with LPS-treated control (NS siRNAtransfected) cells where a high level of VCAM-1 was detected. These results suggest that NFκB is responsible for mediating HuR-induced VCAM-1 up-regulation in LPS-treated HUVECs. HUVECs were transfected with NS or HuR siRNA for 2 days, followed by treatment with mevastatin or recombinant BMP-4 protein for an additional 24 h. Real-time PCR analysis was carried out for HuR (A), Klf2 (B), and BMP-4 (C). Each mRNA level was normalized by that of nontreated (CTRL) and NS siRNA-transfected cells (*, P < 0.05, n = 4).
HuR Functions Through NFκB and IκBα Phosphorylation. To better understand the role of HuR in inflammatory response, we further analyzed the timecourse of expression and phosphorylation of NFκB after LPS treatment, which regulates the expression of VCAM-1 (Fig. 4) . After transfection of HuR siRNA for 3 days, cells were treated with LPS for 15 min, 30 min, and 1 h, respectively, and Western blotting was performed by using the protein samples collected. As shown in Fig. 5 , after as little as 15 min of LPS treatment, the phospho-NFκB p65 level increased greatly in NS siRNA-transfected cells, although the total amount of NFκB remained unchanged. However, with HuR knockdown, the phospho-NFκB had a much smaller increase compared with that in control cells (no LPS treatment). With a longer LPS treatment, this trend remained the same for phospho-NFκB, whereas the total amount of NFκB remained the same. Because phosphorylation of IκBα at ser32/36 (phospho-IκBα) is responsible for the nuclear translocation of NFκB, total IκBα and phospho-IκBα were also quantified by Western blotting. LPS treatment induced phosphorylation of IκBα in NS siRNA-transfected HUVECs, but HuR knockdown inhibited such phosphorylation. This result seemed to be correlated with the inhibition of IKKα/β phosphorylation, which is a key regulatory step of IκBα phosphorylation. Interestingly, the total level of IKKα remained constant with and without the treatments (LPS treatment and HuR knockdown).
To determine whether HuR knockdown alters the effect of statin treatment on NFκB activation, we performed HuR knockdown, statin, and LPS treatments of the same cells and quantified the levels of NFκB phosphorylation and VCAM-1 expression (Fig.  S5 ). As shown in Fig. S5 , in cells with HuR knockdown, no difference could be clearly identified in the amount of phosphorylated NFκB or VCAM-1 expression by statin treatment in combination with LPS treatment. Although there are multiple pathways that affect NFκB phosphorylation by statin (35, 36) , one pathway is the inhibition of IκBα degradation by statin. It is possible that HuR knockdown already reduced IκBα phosphorylation and degradation, thus offsetting the effect of statin on NFκB phosphorylation and VCAM-1 expression after LPS treatment.
Discussion
The results of our cellular studies of monocyte binding to endothelial cells and in vivo studies of HuR expression using a partial ligation model of mouse carotid clearly suggest that HuR plays an important role in mediating inflammatory response by promoting the expression of proatherosclerotic genes and inhibiting the expression of antiatherosclerotic genes. Specifically, we found that the up-regulation of adhesion molecules ICAM-1 and VCAM-1 by LPS treatment can be blocked by lowering the level of HuR; however, this was not accomplished by modifying the mRNA stability, or by direct binding of HuR to the mRNAs of ICAM-1 and VCAM-1 (SI Text and Fig. S6 ). Instead, HuR may directly regulate the upstream transcription factors of these adhesion molecules, such as NFκB. We found that HuR knockdown blocked the phosphorylation of IκBα and IKKα/β, which, in turn, inhibited NFκB activation incited by LPS treatment. Therefore, our results suggest that HuR regulates the phosphorylation of NFκB, IκBα, and IKKα/β, thereby changing the expression of ICAM-1 and VCAM-1, and effecting monocyte adhesion to endothelial cells, a hallmark of inflammatory response.
HuR Does Not Stabilize TLR4 mRNA. It is possible that HuR mediates an inflammatory response by affecting specific mRNAs. It has been reported that HuR stabilizes TLR4 mRNA in vascular aortic smooth muscle cells, thus may play a role in inflammation (22, 37) . However, we found that the half-life of TLR4 mRNA in HUVECs was statistically undistinguishable with and without HuR knockdown (Fig. 6A) . With LPS treatment, the half-life of TLR4 mRNA decreased in cells with HuR knockdown (3.57 h) compared with cells transfected with NS siRNA (6.54 h) (Fig. 6B) . Interestingly, although HuR knockdown alone lowered the TLR4 mRNA level, with LPS treatment, HuR knockdown slightly increased TLR4 mRNA level (Fig. 6C) . Evidently, the inhibition of IκBα phosphorylation in cells with HuR knockdown was not caused by the decrease of TLR4 level. This conclusion is supported by the fact that PMA-induced inflammatory response was also inhibited by HuR knockdown even though the PMA response does not require TLR4.
HuR Does Not Affect AUF1 Protein Level. It is known that HuR can interact or compete with AUF1, another RNA-binding protein that binds to ARE but destabilizes the mRNA, opposite to the reported role of HuR (38) (39) (40) . Therefore, we checked whether HuR knockdown also decreased AUF1 so that the increase in mRNA stability by HuR is counterbalanced by the decrease of AUF1. However, our Western blotting results indicated that there was no significant change of AUF1 protein level before and after LPS treatment, and with and without HuR knockdown (SI Text and Fig. S7 ). These results seem to rule out the possibility that the effect of HuR was counterbalanced by that of AUF1. To reveal the stress sensitivity of HuR and its role in inflammatory response, we have performed in vitro and in vivo experiments that involve mechanical and chemical stresses, including (i) quantifying changes in gene expression in HUVECs in vitro under LS and OS conditions and statin or LPS treatments; (ii) demonstration of changes in HuR expression in vivo under LS and disturbed flows; (iii) determination of the effect of HuR on the expression of adhesion molecules such as VCAM-1 and ICAM-1. Our results clearly suggest that HuR plays an important role in inducing inflammatory response of endothelial cells under mechanical and biochemical stresses. Because HuR is an RNA-binding protein working in the cytosol, it is very unlikely that HuR directly transduces mechanical signal into a biological response. Uncovering the pathway(s) of mechanotransduction that leads to the mechanical stress sensitivity of HuR requires further investigation.
In summary, we demonstrated that in endothelial cells, HuR is a stress-sensitive gene regulated by external stimuli such as flow shear stress and statin treatment. Specifically, we found that the expression of HuR in endothelial cells increases under proatherosclerotic conditions (such as oscillatory shear) and decreases under antiatherosclerotic conditions (such as statin treatment). We also found that HuR regulates the expression of stress-sensitive genes such as antiatherosclerotic genes Klf2 and eNOS, and proatherosclerotic genes such as BMP-4. However, such regulation does not seem to be a result of increased mRNA stability by HuR binding because, for example, HuR knockdown down-regulated Klf2 mRNA levels despite slightly increasing its half-life. Further, we found no direct HuR binding to Klf2 and BMP-4 mRNAs in our RNA-protein immunoprecipitation experiments. Our results revealed that HuR knockdown inhibited inflammatory responses in endothelial cells, including ICAM-1 and VCAM-1 up-regulation, NFκB phosphorylation, and adhesion of monocytes. Tissue staining of the mouse aorta further revealed increased HuR expression in the lesser curvature region of the arch that is exposed to disturbed flow, consistent with our in vitro data. Questions remain as to what is the underlying mechanism of HuR regulation of inflammatory response, and if that is due to a new function of HuR different from stabilizing mRNAs. Answering these questions is left to subsequent studies.
Materials and Methods
HUVECs were cultured in M199 medium supplemented with 20% FBS, heparin (American Pharmaceutical Partners) and endothelial growth factor supplement (isolated in the laboratory). THP-1 monocytes (ATCC) were cultured in RPMI 1640 medium containing 2-mercaptoethanol and 10% FBS. Protocols for shear flow experiments, en face immunohistochemical staining, HuR protein-mRNA immunoprecipitation, chromatin immunoprecipitation assay, and other protocols are described in detail in SI Materials and Methods.
